amdipharm uk limited
amdipharm uk limited Company Information
Company Number
04606340
Website
www.amdipharm.comRegistered Address
dashwood house, 69 old broad street, london, EC2M 1QS
Industry
Other business support service activities n.e.c.
Telephone
08700703033
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
mercury pharma group limited 100%
amdipharm uk limited Estimated Valuation
Pomanda estimates the enterprise value of AMDIPHARM UK LIMITED at £0 based on a Turnover of £0 and 0.52x industry multiple (adjusted for size and gross margin).
amdipharm uk limited Estimated Valuation
Pomanda estimates the enterprise value of AMDIPHARM UK LIMITED at £0 based on an EBITDA of £-11.7k and a 4.08x industry multiple (adjusted for size and gross margin).
amdipharm uk limited Estimated Valuation
Pomanda estimates the enterprise value of AMDIPHARM UK LIMITED at £830.6k based on Net Assets of £366.2k and 2.27x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Amdipharm Uk Limited Overview
Amdipharm Uk Limited is a live company located in london, EC2M 1QS with a Companies House number of 04606340. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in December 2002, it's largest shareholder is mercury pharma group limited with a 100% stake. Amdipharm Uk Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Amdipharm Uk Limited Health Check
There is insufficient data available to calculate a health check for Amdipharm Uk Limited. Company Health Check FAQs
0 Strong
0 Regular
1 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Amdipharm Uk Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Amdipharm Uk Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Amdipharm Uk Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Amdipharm Uk Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (25)
- Amdipharm Uk Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Amdipharm Uk Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Amdipharm Uk Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Amdipharm Uk Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Amdipharm Uk Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Amdipharm Uk Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Amdipharm Uk Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Amdipharm Uk Limited
- - Industry AVG
AMDIPHARM UK LIMITED financials
Amdipharm Uk Limited's latest turnover from December 2022 is 0 and the company has net assets of £366.2 thousand. According to their latest financial statements, we estimate that Amdipharm Uk Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 54,234,151 | 18,802,000 | 21,551,000 | 22,882,000 | 24,367,000 | 25,195,748 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Cost Of Sales | 0 | 0 | 34,721,268 | 14,551,000 | 17,358,000 | 19,137,000 | 20,147,000 | 19,641,814 | ||||||
| Gross Profit | 0 | 0 | 19,512,883 | 4,251,000 | 4,193,000 | 3,745,000 | 4,220,000 | 5,553,934 | ||||||
| Admin Expenses | 0 | 0 | 17,064,058 | 3,689,000 | 7,615,000 | 6,269,000 | 8,895,000 | 8,576,099 | ||||||
| Operating Profit | -11,652 | 31,408 | -13,674 | -6,631 | 0 | 0 | -237,764 | -12,474 | 2,448,825 | 562,000 | -3,422,000 | -2,524,000 | -4,675,000 | -3,022,165 |
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 939,000 | 797,000 | 12,000 | 76 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,697 | 15 | 0 | 128,000 | 8,000 | 0 | 33,931 |
| Pre-Tax Profit | -11,652 | 31,408 | -13,674 | -6,631 | 0 | 0 | 3,733,556 | -10,777 | 2,448,840 | 562,000 | -4,233,000 | -3,313,000 | -4,687,000 | -2,988,310 |
| Tax | 0 | 0 | 16,223 | 0 | 0 | 286,988 | 46,553 | 69,380 | -549,236 | -405,000 | 671,000 | -39,000 | 1,000 | -108,900 |
| Profit After Tax | -11,652 | 31,408 | 2,549 | -6,631 | 0 | 286,988 | 3,780,109 | 58,603 | 1,899,604 | 157,000 | -3,562,000 | -3,352,000 | -4,686,000 | -3,097,210 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 39,061,708 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | -11,652 | 31,408 | 2,549 | -6,631 | 0 | 286,988 | -35,281,599 | 58,603 | 1,899,604 | 157,000 | -3,562,000 | -3,352,000 | -4,686,000 | -3,097,210 |
| Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,327,000 | 5,824,000 | 5,162,000 | 5,671,000 | 4,336,445 | |
| Number Of Employees | 57 | 95 | 93 | 100 | 96 | |||||||||
| EBITDA* | -11,652 | 31,408 | -13,674 | -6,631 | 0 | 0 | -237,764 | -12,474 | 2,448,825 | 1,879,000 | -2,799,000 | -1,779,000 | -3,816,000 | -2,663,753 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,404,000 | 6,705,000 | 7,432,000 | 8,200,602 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 100 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 0 | 1,404,000 | 6,705,000 | 7,432,000 | 8,200,702 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 610,578 | 7,027,000 | 3,356,000 | 5,151,000 | 3,546,000 | 3,039,739 |
| Group Debtors | 366,209 | 377,267 | 362,771 | 373,098 | 378,583 | 452,874 | 6,322 | 47,524,668 | 80,565,157 | 48,334,000 | 174,307,000 | 154,200,000 | 128,517,000 | 100,486,934 |
| Misc Debtors | 0 | 0 | 0 | 500 | 500 | 501 | 92,399 | 49,184 | 106,703 | 30,250,000 | 31,014,000 | 30,279,000 | 30,338,000 | 30,245,178 |
| Cash | 0 | 494 | 17,749 | 20,596 | 21,742 | 11,969 | 60,992 | 72,167 | 556,726 | 12,610,000 | 1,489,000 | 367,000 | 2,407,000 | 6,137,375 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 366,209 | 377,761 | 380,520 | 394,194 | 400,825 | 465,344 | 159,713 | 47,646,019 | 81,839,164 | 98,221,000 | 210,166,000 | 189,997,000 | 164,808,000 | 139,909,226 |
| total assets | 366,209 | 377,861 | 380,620 | 394,294 | 400,925 | 465,444 | 159,813 | 47,646,119 | 81,839,264 | 98,221,000 | 211,570,000 | 196,702,000 | 172,240,000 | 148,109,928 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 245 | 1,358 | 231,010 | 200,000 | 826,000 | 1,187,000 | 2,503,000 | 1,562,587 |
| Group/Directors Accounts | 0 | 0 | 0 | 16,223 | 16,223 | 84,272 | 42,766 | 12,235,054 | 44,949,119 | 58,291,000 | 174,014,000 | 190,048,000 | 161,759,000 | 133,833,443 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 34,167 | 34,167 | 34,167 | 30,637 | 53,255 | 64,561 | 1,372,592 | 6,344,000 | 3,501,000 | 1,817,000 | 1,015,000 | 1,064,175 |
| total current liabilities | 0 | 0 | 34,167 | 50,390 | 50,390 | 114,909 | 96,266 | 12,300,973 | 46,552,721 | 64,835,000 | 178,341,000 | 193,052,000 | 165,277,000 | 136,460,205 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 147,000 | 108,000 | 108,900 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 147,000 | 108,000 | 108,900 |
| total liabilities | 0 | 0 | 34,167 | 50,390 | 50,390 | 114,909 | 96,266 | 12,300,973 | 46,552,721 | 64,835,000 | 178,341,000 | 193,199,000 | 165,385,000 | 136,569,105 |
| net assets | 366,209 | 377,861 | 346,453 | 343,904 | 350,535 | 350,535 | 63,547 | 35,345,146 | 35,286,543 | 33,386,000 | 33,229,000 | 3,503,000 | 6,855,000 | 11,540,823 |
| total shareholders funds | 366,209 | 377,861 | 346,453 | 343,904 | 350,535 | 350,535 | 63,547 | 35,345,146 | 35,286,543 | 33,386,000 | 33,229,000 | 3,503,000 | 6,855,000 | 11,540,823 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | -11,652 | 31,408 | -13,674 | -6,631 | 0 | 0 | -237,764 | -12,474 | 2,448,825 | 562,000 | -3,422,000 | -2,524,000 | -4,675,000 | -3,022,165 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,317,000 | 623,000 | 745,000 | 859,000 | 358,412 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Tax | 0 | 0 | 16,223 | 0 | 0 | 286,988 | 46,553 | 69,380 | -549,236 | -405,000 | 671,000 | -39,000 | 1,000 | -108,900 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -11,058 | 14,496 | -10,827 | -5,485 | -74,292 | 354,654 | -47,475,131 | -33,708,586 | -4,328,562 | -123,066,000 | 19,047,000 | 27,229,000 | 28,629,149 | 133,771,851 |
| Creditors | 0 | 0 | 0 | 0 | 0 | -245 | -1,113 | -229,652 | 31,010 | -626,000 | -361,000 | -1,316,000 | 940,413 | 1,562,587 |
| Accruals and Deferred Income | 0 | -34,167 | 0 | 0 | 3,530 | -22,618 | -11,306 | -1,308,031 | -4,971,408 | 2,843,000 | 1,684,000 | 802,000 | -49,175 | 1,064,175 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -147,000 | 39,000 | -900 | 108,900 |
| Cash flow from operations | -594 | -17,255 | 13,376 | -1,146 | 77,822 | -90,529 | 47,271,501 | 32,227,809 | 1,287,753 | 126,757,000 | -19,999,000 | -29,522,000 | -133,808,842 | |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | -100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | -100 | 100 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | -16,223 | 0 | -68,049 | 41,506 | -12,192,288 | -32,714,065 | -13,341,881 | -115,723,000 | -16,034,000 | 28,289,000 | 27,925,557 | 133,833,443 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,697 | 15 | 0 | -811,000 | -789,000 | -12,000 | 33,855 |
| cash flow from financing | 0 | 0 | -16,223 | 0 | -68,049 | 41,506 | -12,192,288 | -32,712,368 | -13,340,927 | -115,723,000 | 16,443,000 | 27,500,000 | 27,913,734 | 148,505,331 |
| cash and cash equivalents | ||||||||||||||
| cash | -494 | -17,255 | -2,847 | -1,146 | 9,773 | -49,023 | -11,175 | -484,559 | -12,053,274 | 11,121,000 | 1,122,000 | -2,040,000 | -3,730,375 | 6,137,375 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -494 | -17,255 | -2,847 | -1,146 | 9,773 | -49,023 | -11,175 | -484,559 | -12,053,274 | 11,121,000 | 1,122,000 | -2,040,000 | -3,730,375 | 6,137,375 |
amdipharm uk limited Credit Report and Business Information
Amdipharm Uk Limited Competitor Analysis
Perform a competitor analysis for amdipharm uk limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
amdipharm uk limited Ownership
AMDIPHARM UK LIMITED group structure
Amdipharm Uk Limited has 1 subsidiary company.
Ultimate parent company
ADVANZ PHARMA HOLDO LTD
#0148955
2 parents
AMDIPHARM UK LIMITED
04606340
1 subsidiary
amdipharm uk limited directors
Amdipharm Uk Limited currently has 3 directors. The longest serving directors include Mr Vikram Kamath (Mar 2013) and Mr Andreas Stickler (Jan 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Vikram Kamath | United Kingdom | 46 years | Mar 2013 | - | Director |
| Mr Andreas Stickler | 53 years | Jan 2022 | - | Director | |
| Mr Andreas Stickler | 53 years | Jan 2022 | - | Director |
P&L
December 2022turnover
0
0%
operating profit
-11.7k
-137%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
366.2k
-0.03%
total assets
366.2k
-0.03%
cash
0
-1%
net assets
Total assets minus all liabilities
Similar Companies
amdipharm uk limited company details
company number
04606340
Type
Private limited with Share Capital
industry
82990 - Other business support service activities n.e.c.
incorporation date
December 2002
age
22
accounts
Full Accounts
ultimate parent company
previous names
amdipharm limited (May 2013)
amdipharm plc (March 2013)
incorporated
UK
address
dashwood house, 69 old broad street, london, EC2M 1QS
last accounts submitted
December 2022
amdipharm uk limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 6 charges/mortgages relating to amdipharm uk limited. Currently there are 0 open charges and 6 have been satisfied in the past.
amdipharm uk limited Companies House Filings - See Documents
| date | description | view/download |
|---|
